A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients

被引:1
|
作者
Ortiz, Maria [1 ]
Towfic, Fadi [2 ]
Samur, Mehmet Kemal [3 ]
Flynt, Erin [4 ]
Jang, In Sock [5 ]
Wang, Kai [5 ]
Ashby, Cody [6 ]
Walker, Brian A. [6 ]
Trotter, Matthew [7 ]
Morgan, Gareth [8 ]
Munshi, Nikhil [9 ]
Thakurta, Anjan [2 ]
机构
[1] CITRE, Res Analyt, Seville, Spain
[2] Celgene Corp, Summit, NJ USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA
[4] Celgene Corp, Translat Dev & Diagnost, Summit, NJ USA
[5] Celgene Corp, Res Analyt, San Diego, CA USA
[6] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA
[7] CITRE, Seville, Spain
[8] Myeloma Inst Res & Therapy, Little Rock, AR USA
[9] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA USA
关键词
D O I
10.1182/blood-2018-99-117114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3165
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients
    Ely, Scott
    Forsberg, Peter
    Ouansafi, Ihsane
    Rossi, Adriana
    Modin, Alvin
    Pearse, Roger
    Pekle, Karen
    Perry, Arthur
    Coleman, Morton
    Jayabalan, David
    Di Liberto, Maurizio
    Chen-Kiang, Selina
    Niesvizky, Ruben
    Mark, Tomer M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12): : 825 - 833
  • [22] Tandem autologous stem cell transplantation in high-risk patients with newly diagnosed multiple myeloma: Feasibility and preliminary results
    De La Rubia, Javier
    Jimenez, Maria
    Legarda Campo, Mario A.
    Rubio, Lucia
    Frances, Eva
    Jose Cejalvo, Maria
    Ribas, Paz
    Gomez, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E203 - E204
  • [23] Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup
    Ding, Jianghua
    Gong, Shengping
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [24] Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma
    Wong, Daniel
    Reynold, John
    Wellard, Cameron
    Bingham, Nicholas
    Zhao, Jessie
    Ramachandran, Malarmathy
    Quach, Hang
    Gibbs, Simon
    Khong, Tiffany T.
    Mithraprabhu, Sridurga
    Spencer, Andrew
    BLOOD, 2023, 142
  • [25] Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways
    María Ortiz-Estévez
    Fadi Towfic
    Erin Flynt
    Nicholas Stong
    In Sock Jang
    Kai Wang
    Matthew W. B. Trotter
    Anjan Thakurta
    BMC Medical Genomics, 14
  • [26] Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways
    Ortiz-Estevez, Maria
    Towfic, Fadi
    Flynt, Erin
    Stong, Nicholas
    Jang, In Sock
    Wang, Kai
    Trotter, Matthew W. B.
    Thakurta, Anjan
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [27] High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions
    Patrick Hagen
    Jiwang Zhang
    Kevin Barton
    Blood Cancer Journal, 12
  • [28] High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions
    Hagen, Patrick
    Zhang, Jiwang
    Barton, Kevin
    BLOOD CANCER JOURNAL, 2022, 12 (05)
  • [29] Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies
    Charalampous, Charalampos
    Goel, Utkarsh
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie
    Gertz, Morie
    Gonsalves, Wilson
    Hayman, Suzanne
    Hobbs, Miriam
    Hwa, Yi Lisa
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, Vincent
    Kumar, Shaji K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : E329 - E335
  • [30] Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities
    Cavo, Michele
    Bringhen, Sara
    Terragna, Carolina
    Omede, Paola
    Marzocchi, Giulia
    Ruggeri, Marina
    Durante, Sandra
    Petrucci, Maria Teresa
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Montefusco, Vittorio
    Narni, Franco
    Falcone, Antonietta
    Califano, Catello
    Baraldi, Anna
    Pasini, Silvana
    Galieni, Piero
    Morabito, Fortunato
    Grasso, Mariella
    Gottardi, Daniela
    Rizzo, Vincenzo
    Boccadoro, Mario
    Testoni, Nicoletta
    Palumbo, Antonio
    BLOOD, 2010, 116 (21) : 342 - 343